BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16101587)

  • 1. A multivalent recombinant antibody fragment specific for carcinoembryonic antigen.
    Perez L; Ayala M; Pimentel G; Bell H; Canaán-Haden L; Bequet M; González LJ; Miranda M; Ravelo R; Roque L; Acevedo B; Oliva JP; Gavilondo JV
    Biotechnol Appl Biochem; 2006 Jan; 43(Pt 1):39-48. PubMed ID: 16101587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
    Yazaki PJ; Wu AM; Tsai SW; Williams LE; Ikler DN; Wong JY; Shively JE; Raubitschek AA
    Bioconjug Chem; 2001; 12(2):220-8. PubMed ID: 11312683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
    Williams LE; Wu AM; Yazaki PJ; Liu A; Raubitschek AA; Shively JE; Wong JY
    Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody.
    Pietersz GA; Patrick MR; Chester KA
    J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody.
    Li L; Yazaki PJ; Anderson AL; Crow D; Colcher D; Wu AM; Williams LE; Wong JY; Raubitschek A; Shively JE
    Bioconjug Chem; 2006; 17(1):68-76. PubMed ID: 16417253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
    Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
    J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial single-chain antibody fragments, specific for carcinoembryonic antigen.
    Ayala M; Dueñas M; Santos A; Vázquez J; Menéndez A; Silva A; Gavilondo JV
    Biotechniques; 1992 Nov; 13(5):790-9. PubMed ID: 1418981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.
    Hu S; Shively L; Raubitschek A; Sherman M; Williams LE; Wong JY; Shively JE; Wu AM
    Cancer Res; 1996 Jul; 56(13):3055-61. PubMed ID: 8674062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
    Cai W; Olafsen T; Zhang X; Cao Q; Gambhir SS; Williams LE; Wu AM; Chen X
    J Nucl Med; 2007 Feb; 48(2):304-10. PubMed ID: 17268029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and tumor-seeking properties of recombinant and nonrecombinant anti-carcinoembryonic antigen antibody fragments.
    Groulet A; Dorvillius M; Pèlegrin A; Barbet J; Baty D
    Int J Cancer; 2002 Jul; 100(3):367-74. PubMed ID: 12115555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.
    Wu AM; Chen W; Raubitschek A; Williams LE; Neumaier M; Fischer R; Hu SZ; Odom-Maryon T; Wong JY; Shively JE
    Immunotechnology; 1996 Feb; 2(1):21-36. PubMed ID: 9373325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of a single chain anti-CEA antibody from the hybridoma cell line T84.66 using a modified colony-lift selection procedure to detect antigen-positive ScFv bacterial clones.
    Rodenburg CM; Mernaugh R; Bilbao G; Khazaeli MB
    Hybridoma; 1998 Feb; 17(1):1-8. PubMed ID: 9523232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imaging.
    Venisnik KM; Olafsen T; Gambhir SS; Wu AM
    Mol Imaging Biol; 2007; 9(5):267-77. PubMed ID: 17577599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in biodistribution of the anti-(carcinoembryonic antigen) murine monoclonal antibody CE-25, its F(ab')2 fragment and its intact mainly human chimeric form CE 4-8-13. Dependence on tumour size and amount of antibody injected.
    Westera G; Rülicke T; Smith A; Duewell S
    Cancer Immunol Immunother; 1994 Dec; 39(6):375-82. PubMed ID: 8001025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.
    Wu AM; Yazaki PJ; Tsai Sw; Nguyen K; Anderson AL; McCarthy DW; Welch MJ; Shively JE; Williams LE; Raubitschek AA; Wong JY; Toyokuni T; Phelps ME; Gambhir SS
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8495-500. PubMed ID: 10880576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunotherapy of solid tumors: from fairytale to reality.
    Adams GP; Weiner LM
    Cancer Biother Radiopharm; 2001 Feb; 16(1):9-11. PubMed ID: 11279802
    [No Abstract]   [Full Text] [Related]  

  • 19. Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy.
    Kenanova V; Olafsen T; Williams LE; Ruel NH; Longmate J; Yazaki PJ; Shively JE; Colcher D; Raubitschek AA; Wu AM
    Cancer Res; 2007 Jan; 67(2):718-26. PubMed ID: 17234783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mono and bivalent binding of a scFv and covalent diabody to murine laminin-1 using radioiodinated proteins and SPR measurements: effects on tissue retention in vivo.
    Huang BC; Davern S; Kennel SJ
    J Immunol Methods; 2006 Jun; 313(1-2):149-60. PubMed ID: 16750217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.